10/19/2022GSK to Focus on Innovative Medicines and Vaccines to Drive Growth in C...

10/19/2022Viva Biotech Buys Hong Kong CRO SYNthesis to Boost Preclinical Offerin...

10/19/2022The Emergence of Commercial Health Insurances as An Access Route to th...

10/18/2022China's Party Congress Promises Continuity, Not Change (AP)

10/18/2022Xi's Work Report to the 20th Party Congress: 5 Takeaways (The Diplomat...

10/18/2022Financing for China Drugmakers Hits the Lowest of the Year (PharmaDJ)

10/18/2022Report of the CPC 20th Congress: Key Messages Related to Healthcare

10/18/2022NMPA Announces Package Insert Revision of Pentoxifylline Injection

10/17/2022NHSA Announces Conclusion of Expert Evaluation for DRDL Inclusion and ...

10/16/2022SMEI: Chinese Terminal Drug Market Growth Slowed to 1.7% in H1/2022

10/14/2022Singapore Is Becoming a Hotspot for Chinese Drugmakers Looking to Go P...

10/14/2022NMPA Temporarily Extends Timeline for Supplementing Materials of Drug ...

10/14/2022Helsinn Pulls the Plug on Its $2.4B Liver Cancer Deal with BridgeBio

10/14/2022Recent Executive Moves

10/14/2022Drug R&D and Product Registration News Digest October 2022 (1)

10/13/2022IASO and Cabaletta Announce Global License Deal for Clinically Validat...

10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)

10/11/2022AI Poised to Take Chinese Drug Discovery to the Next Level

10/11/2022Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGen...

10/11/2022HanAll's Licensed Partner in China Enters Sublicense Deal with CSPC to...

10/10/2022BGI Genomics Added to U.S. Investment Ban List

10/10/2022CDE Solicits Comments on Draft Technical Guidelines for Microbial Limi...

10/10/2022NMPA Begins Issuance of Electronic Drug Registration Certificate

10/10/2022Genentech and Jemincare Enter $650M Biobucks Pact for Latter's Prosta...

10/10/2022Bayer, Hua Medicine Snag First-In-Class Nod in China for Roche Castoff...

10/9/2022CDE Issues the Technical Guidelines for Bioequivalence Studies of Aspi...

10/9/2022CDE Solicits Comments on Draft Opinions for Reform and Improvement of ...

10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Proto...

10/9/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (63...

Page:124/774 Total number of articles:23208: [First][<<] [122] [123] [124] [125] [126] [>>] [End]